Form 4: HCA Healthcare Executive Sammie S. Mosier Acquires Stock Appreciation Rights

Sammie S. Mosier, a Senior Vice President and Chief Nurse Executive at HCA Healthcare, acquired 4,469 stock appreciation rights on January 28, 2025.

Summary

• Sammie S. Mosier, a Senior Vice President and Chief Nurse Executive at HCA Healthcare, has reported the acquisition of 4,469 stock appreciation rights.
• The transaction occurred on January 28, 2025, at a price of $328.7 per right.
• These stock appreciation rights vest in four equal annual installments starting on January 28, 2026.
• The rights expire on January 28, 2035.
• The underlying security for these rights is 4,469 shares of HCA Healthcare common stock.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, which is generally viewed positively as it aligns executive interests with shareholder value. There is no indication of any negative sentiment.

Positives

• The acquisition of stock appreciation rights by a high-ranking executive like Sammie S. Mosier can be seen as a positive sign of confidence in the company's future performance.

Industry Context

This filing is a routine disclosure of executive compensation in the healthcare industry, where stock-based incentives are common.

Comparison to Industry Standards

• Stock appreciation rights are a common form of executive compensation in publicly traded companies, including those in the healthcare sector.
• The vesting schedule of four equal annual installments is also a typical practice.
• Companies like Tenet Healthcare and Community Health Systems also use similar stock-based compensation plans for their executives.

Stakeholder Impact

• The acquisition of stock appreciation rights by an executive can be seen as a positive sign for shareholders, indicating confidence in the company's future performance.

Key Dates

Keywords

Stock Appreciation Rights, HCA Healthcare, Sammie S. Mosier, Executive Compensation, Insider Trading, Form 4